ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
US Tech 100
18,488.00
-0.25%
Dow Jones
38,798.99
-0.22%
Brent Oil
79.395
0.00%
Bitcoin
69,332.25
0.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) News

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SEEL
DateTimeSourceHeadlineSymbolCompany
06/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
05/31/20244:30PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
05/21/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
05/20/20244:16PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
05/16/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
05/14/202411:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
05/14/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
03/06/20245:32PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
03/06/20244:50PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
03/01/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
02/14/20244:50PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
02/06/20245:26PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
02/02/20246:04AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
01/30/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
01/30/20246:05AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
01/22/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
01/17/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/17/20249:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/10/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
01/08/20249:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/08/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/08/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/08/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
01/02/20248:10AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
12/28/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
12/22/20234:01PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
12/22/20238:10AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
12/20/20234:59PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
12/20/20234:54PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
12/18/20234:54PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SEEL

Your Recent History

COIN
AMGEUR
LSE
LMT
Lombard Medical Technologies
EU
AUC9L
Amundi Finance Emissions...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved